Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

Madhi, SA; Baillie, V; Cutland, CL; Voysey, M; Koen, AL; Fairlie, L; Padayachee, SD; Dheda, K; Barnabas, SL; Bhorat, QE; Briner, C; Kwatra, G; Ahmed, K; Aley, P; Bhikha, S; Bhiman, JN; Bhorat, AE; du Plessis, J; Esmail, A; Groenewald, M; Horne, E; Hwa, SH; Jose, A; Lambe, T; Laubscher, M; Malahleha, M; Masenya, M; Masilela, M; McKenzie, S; Molapo, K; Moultrie, A; Oelofse, S; Patel, F; Pillay, S; Rhead, S; Rodel, H; Rossouw, L; Taoushanis, C; Tegally, H; Thombrayil, A; van Eck, S; Wibmer, CK; Durham, NM; Kelly, EJ; Villafana, TL; Gilbert, S; Pollard, AJ; de Oliveira, T; Moore, PL; Sigal, A; Izu, A

Madhi, SA (corresponding author), Univ Witwatersrand, Princess Wales St, ZA-2193 Parktown, Gauteng, South Africa.

NEW ENGLAND JOURNAL OF MEDICINE, 2021; 384 (20): 1885

Abstract

BACKGROUND Assessment of the safety and efficacy of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different pop......

Full Text Link